Form 4: Argan Inc. CEO David Watson Reports Stock Transactions and Grants

David Watson, President and CEO of Argan Inc., reports stock sales, vesting of restricted stock units, and grants of new restricted stock units and stock options.

Summary

• David Watson, the President and CEO of Argan Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On December 23, 2024, Watson sold 500 shares of common stock at a price of $139.89.
• On April 16, 2025, 1,856 shares vested from Time-Based Restricted Stock Units (TRSUs).
• On April 17, 2025, 2,286 shares vested from TRSUs.
• On April 18, 2025, 1,958 shares vested from TRSUs.
• On April 18, 2025, 11,745 shares vested from Performance-Based Restricted Stock Units (PRSUs).
• On April 16, 2025, Watson was granted 4,000 TRSUs that vest in equal installments over three years starting April 16, 2026.
• On April 16, 2025, Watson received options to purchase 2,000 shares at $148.72, vesting ratably over three years starting April 16, 2026.
• On April 16, 2025, Watson was granted 3,000 PRSUs, vesting based on Argan's Total Stock Return (TSR) compared to peers over three years.
• On April 16, 2025, Watson was granted 7,500 Earnings Per Share Performance-Based Restricted Stock Units (EPSRSUs), vesting based on EPS performance over three years.

Sentiment

Score: 6

Explanation: The document is neutral in tone, simply reporting transactions and grants. The performance-based compensation suggests a positive outlook, but the stock sale is slightly negative.

Positives

• The granting of performance-based restricted stock units (PRSUs and EPSRSUs) aligns management's interests with those of shareholders by tying compensation to company performance.

Future Outlook

The vesting of performance-based restricted stock units (PRSUs and EPSRSUs) is contingent upon the company's future performance, specifically its Total Stock Return (TSR) compared to peers and its Earnings Per Share (EPS) growth over the next three fiscal years.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are common compensation practices among publicly traded companies to incentivize executives.
• Performance-based vesting criteria, such as TSR and EPS targets, are increasingly used to align executive compensation with shareholder value creation.
• The specific terms of these grants, such as vesting schedules and performance targets, are typically benchmarked against industry peers to ensure competitiveness.

Stakeholder Impact

• Shareholders will be interested in the alignment of management's interests with company performance through the performance-based compensation.
• Employees may be indirectly impacted by the performance targets tied to executive compensation.

Next Steps

• Monitor Argan's stock performance and EPS growth to assess the potential payout of the performance-based restricted stock units.
• Review Argan's 2025 Proxy Statement for details on the peer group used for TSR comparison.

Key Dates

Keywords

Form 4, beneficial ownership, stock options, restricted stock units, Argan Inc., David Watson, AGX